Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics.

Pharmacogenetics and genomics - 1 Dec 2010

Brisson Diane, Méthot Julie, Tremblay Karine, Tremblay Monique, Perron Patrice, Gaudet Daniel

Abstract excerpt

UNLABELLED: Hypertriglyceridemia is a frequent and heterogeneous clinical trait, which modulates the risk of disease. Fibrates constitute an effective class of triglyceride-lowering agents. OBJECTIVE: To evaluate the effect of fibrates on fasting plasma triglycerides and other lipids levels in hypertriglyceridemia phenotypes with different genetic and clinical characteristics. METHODS: This study included 146...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Hypertriglyceridemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Treatment Outcome

Share to Triglycerides

Source

Identifiers

PMID: 21217359
DOI: 10.1097/FPC.0b013e328340095e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics.PMID 21217359Read ↗

Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.Semantic proximity Read ↗

Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.Semantic proximity Read ↗

Demystifying the management of hypertriglyceridaemia.Semantic proximity Read ↗

Pro12Ala sequence variant of the PPARG gene is associated with postprandial hypertriglyceridemia in non-E3/E3 patients with the metabolic syndrome.Semantic proximity Read ↗

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia.Semantic proximity Read ↗

A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.Semantic proximity Read ↗

Familial Hypertriglyceridemia: An Entity with Distinguishable Features from other Causes of HypertriglyceridemiaSemantic proximity Read ↗

Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy.Semantic proximity Read ↗

Hypertriglyceridemia.Semantic proximity Read ↗

Allelic and phenotypic spectrum of plasma triglycerides.Semantic proximity Read ↗

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.Semantic proximity Read ↗

Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.